Sophia Genetics SA is expanding its precision oncology research in England by bringing the East Genomics laboratory in Cambridge into the SOPHiA GENETICS network. The laboratory will utilize the SOPHiA DDM™ Platform for cancer profiling, focusing on the analysis of solid tumour samples. This expansion will allow all work to be conducted in-house and aims to enhance the understanding of complex cancers for patients in the East of England.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief on December 15, 2025, and is solely responsible for the information contained therein.